Literature DB >> 28152557

Perinatal outcome of placental massive perivillous fibrin deposition: a case-control study.

Louise Devisme1, Claire Chauvière2, Hélène Franquet-Ansart1, Anastasia Chudzinski2, Morgane Stichelbout1,3, Véronique Houfflin-Debarge2,4, Damien Subtil2,4.   

Abstract

OBJECTIVE: The objectives of the study are to describe the obstetric outcomes associated with massive perivillous fibrin deposition (MFD) compared with a control series and to determine if outcome differs according to the extent of fibrin deposition.
METHOD: Retrospective case-control study based on placentas analyzed over a consecutive 12-year period. MFD was considered severe if it extended over more than 50% of the placenta and moderate between 25% and 50%.
RESULTS: During the study period, MFD was observed on 71 placentas, 39 severe and 32 moderate. Compared with the 142 control women, the 39 women with severe MFD more often had histories of autoimmune disease and intrauterine fetal death. The case women with MFD were associated with elevated levels of maternal alpha-fetoprotein and with a high risk of severe growth restriction and/or intrauterine death. Compared with the infants with moderate MFD, those with severe MFD had also more abnormal umbilical artery Doppler velocimetry findings and more often intrauterine deaths and lower birthweights.
CONCLUSION: Regardless of their extent, MFD that covered at least 25% of the placenta was almost always accompanied by severe growth restriction and by a high risk of intrauterine fetal death. Moreover, severe MFD tend to be associated with autoimmune diseases of the mothers, and pregnancies show more often a pathologic Doppler of the umbilical arteries and more often intrauterine fetal death that the moderate form.
© 2017 John Wiley & Sons, Ltd. © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28152557     DOI: 10.1002/pd.5013

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

Review 1.  The etiology of preeclampsia.

Authors:  Eunjung Jung; Roberto Romero; Lami Yeo; Nardhy Gomez-Lopez; Piya Chaemsaithong; Adithep Jaovisidha; Francesca Gotsch; Offer Erez
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

Review 2.  Chronic Inflammatory Placental Disorders Associated With Recurrent Adverse Pregnancy Outcome.

Authors:  Emily F Cornish; Thomas McDonnell; David J Williams
Journal:  Front Immunol       Date:  2022-04-22       Impact factor: 8.786

3.  Fetal akinesia deformation sequence and massive perivillous fibrin deposition resulting in fetal death in six fetuses from one consanguineous couple, including literature review.

Authors:  Jill K Tjon; Phillis Lakeman; Elisabeth van Leeuwen; Quinten Waisfisz; Marjan M Weiss; Gita M B Tan-Sindhunata; Peter G J Nikkels; Patrick J P van der Voorn; Gajja S Salomons; George L Burchell; Ingeborg H Linskens; Bloeme J van der Knoop; Johanna I P de Vries
Journal:  Mol Genet Genomic Med       Date:  2021-10-12       Impact factor: 2.183

4.  Prenatal diagnosis of multiple large subchorionic placental cysts with intracystic hemorraghe.

Authors:  I Witters; P Sieprath; C Van Holsbeke; C Theyskens; K Deraedt
Journal:  Facts Views Vis Obgyn       Date:  2017-12

5.  Maternal thrombocytopenia precedes fetal death associated with COVID-19.

Authors:  Akihito Sagara; Munekage Yamaguchi; Yoshiki Mikami; Takeshi Motohara; Takashi Ohba; Eiji Kondoh
Journal:  J Obstet Gynaecol Res       Date:  2022-03-12       Impact factor: 1.697

6.  COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy.

Authors:  J E Mongula; M W E Frenken; G van Lijnschoten; N L A Arents; L D de Wit-Zuurendonk; A P A Schimmel-de Kok; P J van Runnard Heimel; M M Porath; S M T A Goossens
Journal:  Ultrasound Obstet Gynecol       Date:  2020-10-19       Impact factor: 8.678

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.